These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 26382316)
1. Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions. Töz E; Özcan A; Balsak D; Avc ME; Eraslan AG; Balc DD Menopause; 2016 Feb; 23(2):138-42. PubMed ID: 26382316 [TBL] [Abstract][Full Text] [Related]
2. Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition. Plusquin C; Fastrez M; Vandromme J; Rozenberg S Maturitas; 2012 Oct; 73(2):164-6. PubMed ID: 22964073 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209 [TBL] [Abstract][Full Text] [Related]
4. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835 [TBL] [Abstract][Full Text] [Related]
5. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial. Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323 [TBL] [Abstract][Full Text] [Related]
6. Factors associated with undergoing bilateral salpingo-oophorectomy at the time of hysterectomy for benign conditions. Jacoby VL; Vittinghoff E; Nakagawa S; Jackson R; Richter HE; Chan J; Kuppermann M Obstet Gynecol; 2009 Jun; 113(6):1259-1267. PubMed ID: 19461420 [TBL] [Abstract][Full Text] [Related]
7. The effect of hysterectomy and bilaterally salpingo-oophorectomy on sexual function in post-menopausal women. Celik H; Gurates B; Yavuz A; Nurkalem C; Hanay F; Kavak B Maturitas; 2008 Dec; 61(4):358-63. PubMed ID: 18977621 [TBL] [Abstract][Full Text] [Related]
8. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Appiah D; Winters SJ; Hornung CA Diabetes Care; 2014; 37(3):725-33. PubMed ID: 24194507 [TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer after hysterectomy and oophorectomy: a nationwide cohort study. Kim M; Kim BH; Lee H; Nam H; Park S; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Kim IJ Eur J Endocrinol; 2021 Jan; 184(1):143-151. PubMed ID: 33112277 [TBL] [Abstract][Full Text] [Related]
10. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study. Obermair A; Youlden DR; Baade PD; Janda M Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248 [TBL] [Abstract][Full Text] [Related]
11. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011. Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772 [TBL] [Abstract][Full Text] [Related]
12. Use of Estrogen Therapy After Surgical Menopause in Women Who Are Premenopausal. Suzuki Y; Huang Y; Melamed A; Clair CMS; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Wright JD Obstet Gynecol; 2022 May; 139(5):756-763. PubMed ID: 35576334 [TBL] [Abstract][Full Text] [Related]
13. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study. Obermair A; Youlden D; Baade P; Janda M Asia Pac J Clin Oncol; 2017 Feb; 13(1):68-78. PubMed ID: 27230709 [TBL] [Abstract][Full Text] [Related]
15. Timing of prophylactic hysterectomy-oophorectomy, mastectomy, and microsurgical breast reconstruction in BRCA1 and BRCA2 carriers. Khansa I; Wang D; Coriddi M; Tiwari P Microsurgery; 2014 May; 34(4):271-6. PubMed ID: 24123194 [TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
17. The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. Moldovan R; Keating S; Clancy T Fam Cancer; 2015 Mar; 14(1):51-60. PubMed ID: 25342222 [TBL] [Abstract][Full Text] [Related]
18. Long-Term Health Consequences After Ovarian Removal at Benign Hysterectomy : A Nationwide Cohort Study. Gottschau M; Rosthøj S; Settnes A; Aalborg GL; Viuff JH; Munk C; Jensen A; Kjær SK; Mellemkjær L Ann Intern Med; 2023 May; 176(5):596-604. PubMed ID: 37068275 [TBL] [Abstract][Full Text] [Related]
19. Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study. Harrington LB; Weiss NS; Wiggins KL; Heckbert SR; McKnight B; Blondon M; Woods NF; LaCroix AZ; Psaty BM; Smith NL Menopause; 2016 Feb; 23(2):143-9. PubMed ID: 26757272 [TBL] [Abstract][Full Text] [Related]
20. Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey. Plusquin C; Fastrez M; Vandromme J; Rozenberg S Maturitas; 2011 Dec; 70(4):391-4. PubMed ID: 22014472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]